Sigma Aldrich Invests in India - Analyst Blog
March 08 2012 - 10:44AM
Zacks
As per industry reports, Sigma Aldrich
Corporation (SIAL), a global lab chemical and life science
company, announced its intention to open a distribution center and
packaging facility in Bengaluru, India and has spent $5 million on
it. The company plans to keep inventory valued at $13 million at
the distribution centre.
The company is actively expanding its presence in the emerging
markets. The prospects of India are considered promising by the
company and thus the expansion. The India operations, Sigma Aldrich
Chemicals Pvt Ltd. had set up its advanced facility for research
and manufacture in Bengaluru which started in August 2006.
The current strength of the Indian operations is 250 and Sigma
Aldrich Chemicals at Benagluru has evolved to meet the global
requirements in the last one and a half years. The Indian unit has
been delivering good double digit growth for the company.
Sigma Aldrich is focused on expansion and recently completed the
acquisition of BioReliance Holdings Inc., a leading
provider of global biopharmaceutical testing services, from Avista
Capital Partners for $350 million in cash. The addition of
BioReliance's industry-leading QA/QC testing services to Sigma’s
product portfolio will enable Sigma to build better and more
customized products.
The acquisition will extend Sigma’s reach into the promising new
market of biologic drugs. Sigma-Aldrich expects the
acquisition to be modestly accretive to its earnings per share in
2012.
Apart from acquisitions, in order to boost its growth
Sigma-Aldrich plans to increase its focus on marketing, business
development and R&D, while continuing with its efforts to
improve process and operations management. Rising costs remain a
key concern for Sigma and the company continues with its efforts to
cut costs.
Sigma-Aldrich faces stiff competition from Bayer
AG (BAYRY) and privately held companies Brenntag AG and
VWR International, LLC. We currently maintain a Zacks #3 Rank
(short-term Hold recommendation) on Sigma and a long-term Neutral
recommendation.
BAYER A G -ADR (BAYRY): Free Stock Analysis Report
SIGMA ALDRICH (SIAL): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
(MM) (NASDAQ:SIAL)
Historical Stock Chart
From Apr 2024 to May 2024
(MM) (NASDAQ:SIAL)
Historical Stock Chart
From May 2023 to May 2024